"Optimists say that the industry, sidelined by the dot-com crash and down economy, will grow as its role becomes more critical in the data-dependent biotech world. Skeptics doubt that bioinformatics will ever live up to expectations.
"We got pretty jazzed about bioinformatics four years ago, but the truth is, we haven't been able to find a single thing to invest in," said Alan Frazier, founder and managing partner of Seattle-based Frazier Healthcare Ventures.
Many investors doubt that bioinformatics companies can make money. The industry became the darling of the investment community in the late 1990s, only to fall through the floor with a number of high-profile burnouts."
“Bioinformatics will be at the core of biology in the 21st century. In fields ranging from structural biology to genomics to biomedical imaging, ready access to data and analytical tools are fundamentally changing the way investigators in the life sciences conduct research and approach problems. Complex, computationally intensive biological problems are now being addressed and promise to significantly advance our understanding of biology and medicine. No biological discipline will be unaffected by these technological breakthroughs.”BIOINFORMATICS IN THE 21st CENTURY
the panda's thumb
bioinformatics.org / nodalpoint / flags and lollipops / on genetics / a bioinformatics blog / andrew dalke / the struggling grad student / in the pipeline / gene expression / free association / pharyngula / the personal genome / genetics and public health blog / the medical informatics weblog / linuxmednews / nanodot / complexity digest /
nsu / nyt science / bbc scitech / newshub / biology news net /
informatics review / stanford / bmj info in practice / bmj info in practice /
look snazzy and support the site at the same time by buying some snowdeal schwag !
valid xhtml 1.0?
This site designed by
Eric C. Snowdeal III .